Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 1999, Chobe Capital is an investment organization based in China and operates under 清科控股 (Zero2IPO Group). The firm focuses on providing investment insights and services within the entrepreneurial and investment sectors. It primarily targets the Chinese market with a significant emphasis on growth equity.
Chobe Capital invests in early-stage and growth-stage companies, concentrating on technology, healthcare, and consumer goods. The firm typically engages in investments within the Chinese market, aiming to support companies that demonstrate strong growth potential.
Chobe Capital has backed notable companies such as 易慕峰生物 (Yimufeng Bio), a global leader in cell therapy for solid tumors; 质子汽车 (Proton Automotive), which specializes in smart driving and new energy vehicles; 莱芒生物 (Laimang Bio), focused on enhanced immune cell therapies; and 擎羽科技 (Qingyu Technology), known for bionic flexible robotics.
To pitch Chobe Capital, email your deck to ranlin@zero2ipo.com.cn.
Chobe Capital focuses on early-stage and growth-stage investments, primarily in the Chinese market.
The firm invests in technology, healthcare, and consumer goods sectors.
Founders can email their pitch decks to ranlin@zero2ipo.com.cn.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.